Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Neurosteroids show promise for treating epilepsy and more research is needed.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Diane 35 plus finasteride is more effective for treating hirsutism.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Finasteride helps reduce priapism in sickle cell anemia patients.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Human hair contains diverse proteins, including keratins and histones, which could help assess hair health and aging.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.